ABBV
Abbvie Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
AbbVie Inc is a prominent American biopharmaceutical firm, founded in 2013 as a spin-off from Abbott Laboratories, dedicated to the research, development, and commercialization of cutting-edge therapies across immunology, oncology, virology, and neuroscience. Renowned for its flagship immunology pro...
$218.64
+1.50% (+$3.24)
Volume
5.16M
52W High
$244.81
52W Low
$177.42
Market Cap
$349.67B
What to Watch This Quarter
Based on historical dataConsensus EPS
$3.77
Whisper EPS
$3.57
5.3% below consensus
Last Quarter
$2.65
Current Streak
1 Meet
Avg Surprise (4Q)
-6.35%
Next Earnings Report
Reports in 61 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
Apr 29, 2026
1-Day:
+3.64%
5-Day:
+2.09%
Q1 2026
Apr 23, 2026
1-Day:
-1.11%
5-Day:
-1.62%
Q4 2025
Feb 4, 2026
1-Day:
+0.88%
5-Day:
+2.83%
Q3 2025
Nov 5, 2025
1-Day:
+1.05%
5-Day:
+0.89%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $15.00B | +12.4% | 83.5% | 31.6% | $699.0M |
| Q4'25 | $16.62B | +10.0% | 72.6% | 35.0% | $1.82B |
| Q3'25 | $15.78B | +9.1% | 66.4% | 12.1% | $186.0M |
| Q2'25 | $15.42B | +6.7% | 71.8% | 31.7% | $938.0M |
| Q1'25 | $13.34B | +8.4% | 70.0% | 28.0% | $1.29B |
| Q4'24 | $15.10B | +5.6% | 70.9% | -9.9% | -$22.0M |
| Q3'24 | $14.46B | +3.8% | 70.9% | 26.5% | $1.56B |
| Q2'24 | $14.46B | +4.3% | 70.9% | 27.6% | $1.37B |
Company Information
Symbol
ABBV
Company
Abbvie Inc
Market Cap
$349.67B
Sector
HEALTHCARE
Next Earnings
Jul 30, 2026
Also Reporting Soon
Companies reporting earnings around the same time as ABBV
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare ABBV with competitors
Side-by-side earnings comparison